Besides, we observed that the treatment with G-CSF was able to prevent or reverse the liver infiltration of fat at 7 dpir, being classified as mild steatosis; however, only the iGCSF-pre-Group maintained this protection at 30 dpir (p = 0.0395), when the iGCSF-post Group already had severe infiltration. The gene discussed is CSF3; the disease is steatosis.